Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention
| Status: | Recruiting |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 14 - 21 |
| Updated: | 2/17/2019 |
| Start Date: | May 1, 2018 |
| End Date: | July 31, 2019 |
| Contact: | David Cordova, PhD |
| Email: | cordovad@umich.edu |
| Phone: | 7347636201 |
The study evaluates the preliminary efficacy of an innovative mobile-health (mHealth)
intervention (hereon referred to as S4E) to improve human immunodeficiency virus and sexually
transmitted infection testing and reduce HIV/STI risk behaviors in a clinic sample (n=100) of
at-risk youth ages 14-21 living in Southeast Michigan. A Stage I randomized control trial
will be conducted to examine the preliminary efficacy of S4E, relative to Usual Care (UC),
over a period of six months.
intervention (hereon referred to as S4E) to improve human immunodeficiency virus and sexually
transmitted infection testing and reduce HIV/STI risk behaviors in a clinic sample (n=100) of
at-risk youth ages 14-21 living in Southeast Michigan. A Stage I randomized control trial
will be conducted to examine the preliminary efficacy of S4E, relative to Usual Care (UC),
over a period of six months.
HIV/STI and drug abuse remain significant public health priorities in the US and youth are
disproportionately affected. Youth between the ages of 15 - 24 constitute 25% of the sexually
experienced population, yet account for 46% and 50% of HIV infections and new STIs,
respectively. National surveillance data indicate that youth disproportionately engage in
HIV/STI risk behaviors, including condomless sex and licit and illicit drug use, which
increase their risk for HIV/STI infection. Despite the disproportionately high rates of
HIV/STI infection and risk behaviors in youth, fewer than 14% report having ever been tested
for HIV and many are not routinely screened for asymptomatic STIs as recommended by the
Center for Disease Control. In Southeast Michigan, HIV/STI are disproportionately high. To
address these significant public health concerns, a mobile-health (mHealth) intervention was
developed for health clinic settings. The proposed research aims to develop a cross-platform
and universal version of S4E. The cross-platform and universal version of S4E will be
compatible with both IOS and Android operating systems, and multiple mobile devices, aimed at
providing adolescents with ongoing access to the intervention once they leave the clinic. The
proposed research will also evaluate the preliminary efficacy of S4E to improve HIV/STI
testing and reduce HIV/STI risk behaviors in a clinic sample (n=100) of at-risk youth ages
14-21 living in Southeast Michigan by conducting a Stage I RCT to examine the preliminary
efficacy of S4E, relative to Usual Care, among a sample of 100 at-risk youth over six months.
disproportionately affected. Youth between the ages of 15 - 24 constitute 25% of the sexually
experienced population, yet account for 46% and 50% of HIV infections and new STIs,
respectively. National surveillance data indicate that youth disproportionately engage in
HIV/STI risk behaviors, including condomless sex and licit and illicit drug use, which
increase their risk for HIV/STI infection. Despite the disproportionately high rates of
HIV/STI infection and risk behaviors in youth, fewer than 14% report having ever been tested
for HIV and many are not routinely screened for asymptomatic STIs as recommended by the
Center for Disease Control. In Southeast Michigan, HIV/STI are disproportionately high. To
address these significant public health concerns, a mobile-health (mHealth) intervention was
developed for health clinic settings. The proposed research aims to develop a cross-platform
and universal version of S4E. The cross-platform and universal version of S4E will be
compatible with both IOS and Android operating systems, and multiple mobile devices, aimed at
providing adolescents with ongoing access to the intervention once they leave the clinic. The
proposed research will also evaluate the preliminary efficacy of S4E to improve HIV/STI
testing and reduce HIV/STI risk behaviors in a clinic sample (n=100) of at-risk youth ages
14-21 living in Southeast Michigan by conducting a Stage I RCT to examine the preliminary
efficacy of S4E, relative to Usual Care, among a sample of 100 at-risk youth over six months.
Inclusion Criteria:
- Female or male youth 14-21 years of age
- Sexually active
- Live in Southeast Michigan
- Have access to a smartphone or tablet
- Youth must see an enrolled clinician to participate in the study.
Exclusion Criteria:
- Report of prior psychiatric hospitalization by adolescent
- Visible cognitive impairment due to drug use
- Adolescent reports (tentative or firm) plans to move out of the Southeast Michigan
area during the study
We found this trial at
1
site
Click here to add this to my saved trials
